CMS certification 054144
UCSF Langley Porter Psychiatric Hospital and Clinics
1600 Divisadero Street, 7th Floor, San Francisco, CA 94143
This page brings together federal quality data for this hospital: its CMS star rating, patient survey results, emergency department times, and death, complication, infection and readmission rates, each compared with the national rate. Everything here comes from CMS and NPPES, the federal sources themselves - not from us.
Clinicians registered at this address
119 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 6 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Diagnostic Radiology | 14 |
| Genetic Counselor, MS | 14 |
| Internal Medicine | 12 |
| Radiation Oncology | 10 |
| Surgery | 7 |
| Anesthesiology | 6 |
| Nurse Practitioner | 6 |
| Medical Oncology | 4 |
| Surgical Oncology | 4 |
| Nurse Anesthetist, Certified Registered | 3 |
| Obstetrics & Gynecology | 3 |
| Pharmacist | 3 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $66.9M
- 2020 $69.7M
- 2021 $58.9M
- 2022 $73.7M
- 2023 $73.3M
- 2024 $80.5M
- 2025 $69.8M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Grants | $3.4M | 77 |
| Speaking, teaching and other services | $1.5M | 177 |
| Space rental and facility fees | $980,229 | 180 |
| Consulting fees | $824,730 | 14 |
| Education | $288,125 | 14 |
| Royalties and licensing fees | $120,773 | 19 |
| Medical devices and supplies on long-term loan | $92,789 | 8 |
| Gifts | $33,088 | 4 |
| Charitable contributions | $20,700 | 5 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Genentech, Inc. | $12.1M | 182 |
| Merck Sharp & Dohme LLC | $8.9M | 73 |
| Abbott Laboratories | $4M | 66 |
| E.R. Squibb & Sons, L.L.C. | $3.5M | 51 |
| AstraZeneca Pharmaceuticals LP | $3.2M | 27 |
| F. Hoffmann-La Roche AG | $3.1M | 116 |
| Pfizer INC. | $2.6M | 213 |
| Janssen Research & Development, LLC | $2.3M | 216 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| ISM2512043A-Traumatic Brain Injury (TBI) test for diagnosis and determination of severity of brain injury in adults and children Abbott Laboratories | $3.5M |
| A Phase 2 Study of Pembrolizumab Plus 177Lu-PSMA-617 in Patients with Metastatic Castration Resistant Prostate Cancer Merck Sharp & Dohme LLC | $2.1M |
| STUDY NAME#A phase II study of stereotactic radiosurgery in conjunction with PD-1 inhibitor Pembrolizumab for the treatment of recurrent meningioma. Merck Sharp & Dohme LLC | $1.9M |
| Evaluation of Fenebrutinib in RMS patients Genentech, Inc. | $1.9M |
| Phase II Trial of the Efficacy of AZD6738 Alone and in Combination with Olaparib in Patients with BAF250a-Deficient or BAF250a-Expressing Selected So… AstraZeneca Pharmaceuticals LP | $1.2M |
| IMPACT Genentech, Inc. | $1.1M |
| MARVELHCM: RealWorld Outcomes of Mavacamten Monotherapy in Obstructive Hypertrophic Cardiomyopathy E.R. Squibb & Sons, L.L.C. | $1.1M |
| A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 509 in Subjects With Metastatic Castration-Resistant Prost… Amgen Inc. | $1M |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
Common questions about UCSF Langley Porter Psychiatric Hospital and Clinics
Does UCSF Langley Porter Psychiatric Hospital and Clinics have an emergency room?
No. CMS does not list emergency services at UCSF Langley Porter Psychiatric Hospital and Clinics.
Does UCSF Langley Porter Psychiatric Hospital and Clinics receive money from drug and device companies?
Drug and device makers reported $69.8M in payments to UCSF Langley Porter Psychiatric Hospital and Clinics for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.